184 related articles for article (PubMed ID: 35391504)
1. Bioinformatics detection of modulators controlling splicing factor-dependent intron retention in the human brain.
Chen SX; Simpson E; Reiter JL; Liu Y
Hum Mutat; 2022 Nov; 43(11):1629-1641. PubMed ID: 35391504
[TBL] [Abstract][Full Text] [Related]
2. Splicing Enhancers at Intron-Exon Borders Participate in Acceptor Splice Sites Recognition.
Kováčová T; Souček P; Hujová P; Freiberger T; Grodecká L
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911621
[TBL] [Abstract][Full Text] [Related]
3. Upstream analysis of alternative splicing: a review of computational approaches to predict context-dependent splicing factors.
Carazo F; Romero JP; Rubio A
Brief Bioinform; 2019 Jul; 20(4):1358-1375. PubMed ID: 29390045
[TBL] [Abstract][Full Text] [Related]
4. An important class of intron retention events in human erythroblasts is regulated by cryptic exons proposed to function as splicing decoys.
Parra M; Booth BW; Weiszmann R; Yee B; Yeo GW; Brown JB; Celniker SE; Conboy JG
RNA; 2018 Sep; 24(9):1255-1265. PubMed ID: 29959282
[TBL] [Abstract][Full Text] [Related]
5. SRSF2 directly inhibits intron splicing to suppresses cassette exon inclusion.
Moon H; Cho S; Loh TJ; Jang HN; Liu Y; Choi N; Oh J; Ha J; Zhou J; Cho S; Kim DE; Ye MB; Zheng X; Shen H
BMB Rep; 2017 Aug; 50(8):423-428. PubMed ID: 28712387
[TBL] [Abstract][Full Text] [Related]
6. FUBP1 is a general splicing factor facilitating 3' splice site recognition and splicing of long introns.
Ebersberger S; Hipp C; Mulorz MM; Buchbender A; Hubrich D; Kang HS; Martínez-Lumbreras S; Kristofori P; Sutandy FXR; Llacsahuanga Allcca L; Schönfeld J; Bakisoglu C; Busch A; Hänel H; Tretow K; Welzel M; Di Liddo A; Möckel MM; Zarnack K; Ebersberger I; Legewie S; Luck K; Sattler M; König J
Mol Cell; 2023 Aug; 83(15):2653-2672.e15. PubMed ID: 37506698
[TBL] [Abstract][Full Text] [Related]
7. Serine and arginine rich splicing factor 1 deficiency alters pathways involved in IL-17A expression and is implicated in human psoriasis.
Su S; Katopodi XL; Pita-Juarez YH; Maverakis E; Vlachos IS; Adamopoulos IE
Clin Immunol; 2022 Jul; 240():109041. PubMed ID: 35613697
[TBL] [Abstract][Full Text] [Related]
8. SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells.
Shultz JC; Goehe RW; Murudkar CS; Wijesinghe DS; Mayton EK; Massiello A; Hawkins AJ; Mukerjee P; Pinkerman RL; Park MA; Chalfant CE
Mol Cancer Res; 2011 Jul; 9(7):889-900. PubMed ID: 21622622
[TBL] [Abstract][Full Text] [Related]
9. TIMP1 intron 3 retention is a marker of colon cancer progression controlled by hnRNPA1.
Flodrops M; Dujardin G; Busson A; Trouvé P; Ka C; Simon B; Arzur D; Le Jossic-Corcos C; Corcos L
Mol Biol Rep; 2020 Apr; 47(4):3031-3040. PubMed ID: 32200451
[TBL] [Abstract][Full Text] [Related]
10. Targeting serine- and arginine-rich splicing factors to rectify aberrant alternative splicing.
Li D; Yu W; Lai M
Drug Discov Today; 2023 Sep; 28(9):103691. PubMed ID: 37385370
[TBL] [Abstract][Full Text] [Related]
11. Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify.
Komor MA; Pham TV; Hiemstra AC; Piersma SR; Bolijn AS; Schelfhorst T; Delis-van Diemen PM; Tijssen M; Sebra RP; Ashby M; Meijer GA; Jimenez CR; Fijneman RJA
Mol Cell Proteomics; 2017 Oct; 16(10):1850-1863. PubMed ID: 28747380
[TBL] [Abstract][Full Text] [Related]
12. LncRNA-dependent nuclear stress bodies promote intron retention through SR protein phosphorylation.
Ninomiya K; Adachi S; Natsume T; Iwakiri J; Terai G; Asai K; Hirose T
EMBO J; 2020 Feb; 39(3):e102729. PubMed ID: 31782550
[TBL] [Abstract][Full Text] [Related]
13. Activation of Cryptic 3' Splice-Sites by SRSF2 Contributes to Cassette Exon Skipping.
Moon H; Jang HN; Liu Y; Choi N; Oh J; Ha J; Zheng X; Shen H
Cells; 2019 Jul; 8(7):. PubMed ID: 31295920
[TBL] [Abstract][Full Text] [Related]
14. SRSF1 suppresses selection of intron-distal 5' splice site of DOK7 intron 4 to generate functional full-length Dok-7 protein.
Ahsan KB; Masuda A; Rahman MA; Takeda JI; Nazim M; Ohkawara B; Ito M; Ohno K
Sci Rep; 2017 Sep; 7(1):10446. PubMed ID: 28874828
[TBL] [Abstract][Full Text] [Related]
15. Dynamics and functional roles of splicing factor autoregulation.
Ding F; Su CJ; Edmonds KK; Liang G; Elowitz MB
Cell Rep; 2022 Jun; 39(12):110985. PubMed ID: 35732114
[TBL] [Abstract][Full Text] [Related]
16. Minor intron splicing revisited: identification of new minor intron-containing genes and tissue-dependent retention and alternative splicing of minor introns.
Olthof AM; Hyatt KC; Kanadia RN
BMC Genomics; 2019 Aug; 20(1):686. PubMed ID: 31470809
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of alternative splicing contributes to multiple myeloma pathogenesis.
Song S; Zhang W; Li Q; Wang Z; Su Q; Zhang X; Li B; Zhuang W
Br J Cancer; 2023 Apr; 128(6):1086-1094. PubMed ID: 36593359
[TBL] [Abstract][Full Text] [Related]
18. m
Ninomiya K; Iwakiri J; Aly MK; Sakaguchi Y; Adachi S; Natsume T; Terai G; Asai K; Suzuki T; Hirose T
EMBO J; 2021 Aug; 40(15):e107976. PubMed ID: 34184765
[TBL] [Abstract][Full Text] [Related]
19. SRSF1-Regulated Alternative Splicing in Breast Cancer.
Anczuków O; Akerman M; Cléry A; Wu J; Shen C; Shirole NH; Raimer A; Sun S; Jensen MA; Hua Y; Allain FH; Krainer AR
Mol Cell; 2015 Oct; 60(1):105-17. PubMed ID: 26431027
[TBL] [Abstract][Full Text] [Related]
20. SRSF5 regulates alternative splicing of
Li J; Li G; Qi Y; Lu Y; Wang H; Shi K; Li D; Shi J; Stovall DB; Sui G
RNA Biol; 2021 Oct; 18(sup1):318-336. PubMed ID: 34291726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
